花园生物：关于2022年员工持股计划出售完毕暨终止的公告

Group 1 - The company Garden Biologics announced the complete sale of 7,674,790 shares held under its 2022 employee stock ownership plan, representing 1.41% of the total share capital [2] - The sale was conducted in compliance with market trading rules and regulations set by the China Securities Regulatory Commission and Shenzhen Stock Exchange, ensuring no insider trading occurred [2] - Following the sale, the company will proceed with the asset settlement and distribution related to the employee stock ownership plan and will terminate the plan as per regulations [2]